Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Francesco Spina, Paolo Emilio Alessandrino, Raffaella Milani, Francesca Bonifazi, Massimo Bernardi, Roberto Luksch, Franca Fagioli, Chiara Formica & Lucia Farina. (2012) Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of transplant. Leukemia & Lymphoma 53:1, pages 96-102.
Read now
Read now
María S. Felice, Jorge Rossi, Marta Gallego, Pedro A. Zubizarreta, Ana M. Cygler, Elizabeth Alfaro & Federico Sackmann-Muriel. (1999) Acute Trilineage Leukemia with Monosomy of Chromosome 7 Following an Acute Promyelocytic Leukemia. Leukemia & Lymphoma 34:3-4, pages 409-413.
Read now
Read now
Carlo Aul, Norbert Gattermann & Wolfgang Schneider. (1995) Epidemiological and Etiological Aspects of Myelodysplastic Syndromes. Leukemia & Lymphoma 16:3-4, pages 247-262.
Read now
Read now
Articles from other publishers (26)
Ossama M. Maher, Jorge Galvez Silva, Jimin Wu, Diane Liu, Laurence J.N. Cooper, Nidale Tarek, Laura Worth, Dean A. Lee, Demetrios Petropoulos, Anna R.K. Franklin, Patrick Zweidler-Mckay, Robert J. Wells, Gabriela Rondon, Richard E. Champlin & Priti Tewari. (2017) Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experience. Pediatric Transplantation 21:3, pages e12890.
Crossref
Crossref
. 2014. Morphology of Blood Disorders. Morphology of Blood Disorders
285
421
.
Henk van den Berg. (2014) Treatment related myeloid malignancies in childhood. Hematology and Leukemia 2:1, pages 3.
Crossref
Crossref
Karina Sugita, Yoshihiro Hatta, Katsuhiro Miura, Daisuke Kurita, Yujin Kobayashi, Toshitake Tanaka, Hikari Ishizuka, Kazuhiro Takei, Sumiko Kobayashi, Shin Aizawa, Masahiko Sugitani & Jin Takeuchi. (2010) Development of Acute Monocytic Leukemia in a Patient after Chemotherapy for non-Hodgkin's Lymphoma. Journal of Nihon University Medical Association 69:3, pages 193-197.
Crossref
Crossref
Sergej N. Konoplev & Carlos E. Bueso-Ramos. 2010. Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology of Hematolymphoid Diseases
463
471
.
Hung Chang, Chuang Chi Liaw & Hsien Kun Chang. (2018) Therapy-Related Acute Myeloid Leukemia after Concurrent Chemoradiotherapy for Esophageal Cancer: Report of Two Cases. Tumori Journal 95:3, pages 371-373.
Crossref
Crossref
S. Gujral, Y. Badrinath, A. Kumar, P. G. Subramanian, G. Raje, H. Jain, A. Pais, P. S. Amre Kadam, S. D. Banavali, B. Arora, P. Kumar, V. G. Hari Menon, P. A. Kurkure, P. M. Parikh, S. Mahadik, A. B. Chogule, S. C. Shinde & C. N. Nair. (2009) Immunophenotypic profile of acute leukemia: Critical analysis and insights gained at a tertiary care center in India. Cytometry Part B: Clinical Cytometry 76B:3, pages 199-205.
Crossref
Crossref
Nathan A. EllisDezheng Huo, Ozlem Yildiz, Lisa J. Worrillow, Mekhala BanerjeeMichelle M. Le BeauRichard A. LarsonJames M. Allan & Kenan Onel. (2008) MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood 112:3, pages 741-749.
Crossref
Crossref
Faramarz Naeim & P. Nagesh Rao. 2008. Hematopathology. Hematopathology
207
255
.
Attilio Orazi. (2007) Histopathology in the Diagnosis and Classification of Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Myelodysplastic/Myeloproliferative Diseases. Pathobiology 74:2, pages 97-114.
Crossref
Crossref
A. Fletcher. (2006) Haematology. Journal of the Royal Army Medical Corps 152:4, pages 250-265.
Crossref
Crossref
K. B. Kim, S. Faderl, C. S. Hwang & F. R. Khuri. (2006) Chronic myelomonocytic leukaemia after platinum-based therapy for non-small cell lung cancer: case report and review of the literature. Journal of Clinical Pharmacy and Therapeutics 31:4, pages 401-406.
Crossref
Crossref
Attilio Orazi, Dennis P. O'Malley & Daniel A. Arber. 2009. Illustrated Pathology of the Bone Marrow. Illustrated Pathology of the Bone Marrow
43
57
.
Sergej Konoplev & Carlos E. Bueso-Ramos. (2006) Advances in the pathologic diagnosis and biology of acute myeloid leukemia. Annals of Diagnostic Pathology 10:1, pages 39-65.
Crossref
Crossref
Mitsuhiro Suenaga, Kakushi Matsushita, Nakaaki Kawamata, Toshimasa Kukita, Yuji Hamakawa, Kentaro Gejima, Reiri Onodera, Tetsuo Sato, Akihiko Yamaguchi, Hirosaka Inoue, Kosei Arimura, Naomichi Arima, Hiroki Yoshida & Chuwa Tei. (2006) True Malignant Histiocytosis with Trisomy 9 following Primary Mediastinal Germ Cell Tumor. Acta Haematologica 116:1, pages 62-66.
Crossref
Crossref
Richard D. Brunning. 2009. Myelodysplastic Syndromes. Myelodysplastic Syndromes
33
62
.
Roger S. Riley, Michael Idowu, Alden Chesney, Shawn Zhao, John McCarty, Lawrence S. Lamb & Jonathan M. Ben‐Ezra. (2005) Hematologic aspects of myeloablative therapy and bone marrow transplantation. Journal of Clinical Laboratory Analysis 19:2, pages 47-79.
Crossref
Crossref
C Schoch, W Kern, S Schnittger, W Hiddemann & T Haferlach. (2003) Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 18:1, pages 120-125.
Crossref
Crossref
Peter Valent, Friedrich Wimazal, Ilse Schwarzinger, Wolfgang R. Sperr & Klaus Geissler. (2003) Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)Pathogenese, Klassifikation und Therapie der myelodysplastischen Syndrome. Wiener Klinische Wochenschrift 115:13-14, pages 515-536.
Crossref
Crossref
John F. SeymourBarbara ProLillian M. FullerJohn T. ManningFredrick B. HagemeisterJorge RomagueraMaria A. RodriguezChul S. HaTerry L. SmithAna AyalaMark HessJames D. CoxFernando CabanillasPeter McLaughlin. (2003) Long-Term Follow-Up of a Prospective Study of Combined Modality Therapy for Stage I–II Indolent Non-Hodgkin’s Lymphoma. Journal of Clinical Oncology 21:11, pages 2115-2122.
Crossref
Crossref
Claudia Schoch & Torsten Haferlach. (2002) Cytogenetics in acute myeloid leukemia. Current Oncology Reports 4:5, pages 390-397.
Crossref
Crossref
PM Carli, C Sgro, N Parchin-Geneste, N Isambert, F Mugneret, F Girodon & M Maynadié. (2000) Increase therapy-related leukemia secondary to breast cancer. Leukemia 14:6, pages 1014-1017.
Crossref
Crossref
A.M. Al-Homaidhi, B. Patterson, S. Rubin & J.H. Lipton. (1999) Acute lymphoblastic leukemia with multiple cytogenetic abnormalities secondary to treatment of Ewing’s sarcoma. Leukemia Research 23:6, pages 593-596.
Crossref
Crossref
Maria S. Felice, Pedro A. Zubizarreta, Guillermo L. Chantada, Elizabeth Alfaro, Ana M. Cygler, Marta Gallego, Jorge Rossi & Federico Sackmann-Muriel. (1998) Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina. Medical and Pediatric Oncology 30:3, pages 160-164.
Crossref
Crossref
Elaine R. Morgan & Maureen Haugen. 1997. Diagnostic and Therapeutic Advances in Pediatric Oncology. Diagnostic and Therapeutic Advances in Pediatric Oncology
343
375
.
Flora E. Van Leeuwen. (1996) 4 Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment. Baillière's Clinical Haematology 9:1, pages 57-85.
Crossref
Crossref